Welcoming Dr Amol to the Infinia Sciences !

Rahila Deshmukh-Head of the Project Department

Tolfenamic Acid

At Infinia Sciences, we specialize in providing high-quality pharmaceutical intermediates and APIs for global innovators.

🧪 Tolfenamic Acid –
➡ IUPAC Name: 2-(3-chloro-2-methylanilino) benzoic acid
➡ Molecular Weight: 261.70 g/mol
➡ CAS No.: 13710-19-5
➡ Physical Form: Off-white solid
➡ Storage Condition: Store below 25°C

🌍 Backed by our state-of-the-art facilities and stringent quality control systems, Infinia Sciences is your trusted CRO & CDMO partner in pharma innovation.

Infinia Sciences Pvt Ltd

Mrs Prerana Patil
Founder, Chairman & Managing Director

Infinia Sciences Pvt Ltd, MIDC Bhosari, Pune

Mrs Prerana Patil, an entrepreneur with 20+ years of diverse experience in various industries like Pharma, Chemicals, Agriculture, Automobiles, and Real estate, etc and also Founder, Chairman & Managing Director of Infinia Sciences Pvt Ltd, MIDC Bhosari, Pune.

 

Mrs Prerana Patil thrilled to announce that Infinia Sciences Pvt Ltd, Pune has been internationally recognised and started working with several US biotech companies and US Universities on New Chemical Entities synthesis essential for Cancer Research Project. A new medicine for Cancer treatment is key and focused area for all Scientists across the world. The company is also collaborated with several universities such Bharati Vidyapeeth Pune and supporting them for the cutting-edge research activities for the development of students and faculties vision for new medicines.

 

Infinia Sciences Pvt. Ltd. Pune is a leading Contract Research Organization (CRO), Contract Research and Manufacturing Services (CRAMS) and CDMO company supporting to several clients nationally and internationally. The company started in Jul 2021 and made phenomenal growth in the 3-4 years (2022-2025). Mrs Prerana also added that there will be various opportunities for employment at this company as we are making our foot print across the globe. The company has a very strong foundation for all the scientific activities, learning new innovation, technology, and chemistry solutions from mg, Kg, and Metric ton scales.

DSIR Approved Facility

Infinia Sciences Private Limited
A Leading CRO, CRAMS, and CDMO Company | DSIR Approved Facility

At Infinia Sciences, we deliver comprehensive support to pharmaceutical and biotech industries — from research and development to manufacturing — with a strong focus on quality, compliance, and innovation.

We also offer a wide range of analytical services, including:

• HPLC
• LC-MS
• DI Mass
• Preparative HPLC Purification
• Chiral HPLC
• Lyophilization
• Titrimetric Analysis
• LOD by KF
• Melting Point Determination
• GC Analysis

Our commitment is to provide reliable, high-quality solutions to accelerate your drug discovery and development pipeline.

Let’s collaborate to bring science to life.

Exciting Announcement

We are thrilled to welcome Dr. Vivek S. Gaware to Infinia Sciences as our new Principal Scientist, CRO R&D. With over 15 years of industrial experience in drug discovery (NCE), CRO FTEs, and FFS projects, Dr. Vivek brings a wealth of expertise to our team.
Dr. Vivek earned his PhD in Synthetic Organic Chemistry from the University of Iceland, Reykjavik, and completed his Postdoc fellowship there as well. During his academic journey, he collaborated closely with PCI Biotech (Norwegian Biotech company) and participated in numerous international conferences across Europe and the US.
His career spans prestigious organizations such as NCL Pune, Glenmark Pharmaceuticals, Nycomed Pharmaceuticals, S.H. Kelkar Company Ltd (Keva), Laxai Life Sciences, and Sai Life Sciences. Dr. Vivek has led several challenging research projects, showcasing excellent project management, team leadership, and work ethic.
Dr. Vivek has authored 11 peer-reviewed international journal articles, holds 2 patents, and contributed to 1 book chapter, underlining his commitment to scientific excellence and innovation.
We are excited to have Dr. Vivek join us and look forward to the impact he will make as we continue advancing our R&D capabilities!
Welcome aboard, Dr. Vivek! 🚀🔬